Asia Pacific Pharmacovigilance and Drug Safety Software Market Report (2021-2031) by Scope, Segmentation, Dynamics, and Competitive Analysis
The Asia Pacific Pharmacovigilance and Drug Safety Software Market size was valued at US$ 44.40 Mn in 2023 and is projected to reach US$ 68.66 Mn by 2031, growing at a CAGR of 5.6% during 2023 - 2031.
Report Coverage
- Offering: Software, Services
- Deployment: Cloud, On-Premises
- Enterprise Size: Large Enterprises, SMEs
- Form: Standard, Customized
US$ 44.40 Mn
Market size in 2023
US$ 68.66 Mn
Market Size by 2031
5.6%
CAGR, 2023 - 2031
2024-2031
Forecast Period
1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. Asia Pacific Pharmacovigilance and Drug Safety Software Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. Asia Pacific Pharmacovigilance and Drug Safety Software Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. Asia Pacific Pharmacovigilance and Drug Safety Software Market Regional Analysis
6.2 Asia Pacific Pharmacovigilance and Drug Safety Software Market Revenue 2021-2031 (US$ Million)
6.3 Asia Pacific Pharmacovigilance and Drug Safety Software Market Forecast Analysis
7. Asia Pacific Pharmacovigilance and Drug Safety Software Market Analysis – by Offering
7.1 Software
- 7.1.1 Overview
- 7.1.2 Software: Asia Pacific Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast, 2021-2031 (US$ Million)
7.2 Services
- 7.2.1 Overview
- 7.2.2 Services: Asia Pacific Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast, 2021-2031 (US$ Million)
8. Asia Pacific Pharmacovigilance and Drug Safety Software Market Analysis – by Deployment
8.1 Cloud
- 8.1.1 Overview
- 8.1.2 Cloud: Asia Pacific Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast, 2021-2031 (US$ Million)
8.2 On-Premises
- 8.2.1 Overview
- 8.2.2 On-Premises: Asia Pacific Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast, 2021-2031 (US$ Million)
9. Asia Pacific Pharmacovigilance and Drug Safety Software Market Analysis – by Enterprise Size
9.1 Large Enterprises
- 9.1.1 Overview
- 9.1.2 Large Enterprises: Asia Pacific Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast, 2021-2031 (US$ Million)
9.2 SMEs
- 9.2.1 Overview
- 9.2.2 SMEs: Asia Pacific Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast, 2021-2031 (US$ Million)
10. Asia Pacific Pharmacovigilance and Drug Safety Software Market Analysis – by Form
10.1 Standard
- 10.1.1 Overview
- 10.1.2 Standard: Asia Pacific Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast, 2021-2031 (US$ Million)
10.2 Customized
- 10.2.1 Overview
- 10.2.2 Customized: Asia Pacific Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast, 2021-2031 (US$ Million)
11. Asia Pacific Pharmacovigilance and Drug Safety Software Market – Asia Pacific Analysis
11.1 Overview
11.2 Asia Pacific- 11.2.1 Asia Pacific Pharmacovigilance and Drug Safety Software Market Breakdown, by Key Country, 2024 and 2031 (%)
- 11.2.1.1 Asia Pacific Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast Analysis – by Country
- 11.2.1.1 Australia: Asia Pacific Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031 (US$ Million)
- 11.2.1.1.1 Australia: Asia Pacific Pharmacovigilance and Drug Safety Software Market Breakdown, by Offering
- 11.2.1.1.2 Australia: Asia Pacific Pharmacovigilance and Drug Safety Software Market Breakdown, by Deployment
- 11.2.1.1.3 Australia: Asia Pacific Pharmacovigilance and Drug Safety Software Market Breakdown, by Enterprise Size
- 11.2.1.1.4 Australia: Asia Pacific Pharmacovigilance and Drug Safety Software Market Breakdown, by Form
- 11.2.1.2 China: Asia Pacific Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031 (US$ Million)
- 11.2.1.2.1 China: Asia Pacific Pharmacovigilance and Drug Safety Software Market Breakdown, by Offering
- 11.2.1.2.2 China: Asia Pacific Pharmacovigilance and Drug Safety Software Market Breakdown, by Deployment
- 11.2.1.2.3 China: Asia Pacific Pharmacovigilance and Drug Safety Software Market Breakdown, by Enterprise Size
- 11.2.1.2.4 China: Asia Pacific Pharmacovigilance and Drug Safety Software Market Breakdown, by Form
- 11.2.1.3 India: Asia Pacific Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031 (US$ Million)
- 11.2.1.3.1 India: Asia Pacific Pharmacovigilance and Drug Safety Software Market Breakdown, by Offering
- 11.2.1.3.2 India: Asia Pacific Pharmacovigilance and Drug Safety Software Market Breakdown, by Deployment
- 11.2.1.3.3 India: Asia Pacific Pharmacovigilance and Drug Safety Software Market Breakdown, by Enterprise Size
- 11.2.1.3.4 India: Asia Pacific Pharmacovigilance and Drug Safety Software Market Breakdown, by Form
- 11.2.1.4 Japan: Asia Pacific Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031 (US$ Million)
- 11.2.1.4.1 Japan: Asia Pacific Pharmacovigilance and Drug Safety Software Market Breakdown, by Offering
- 11.2.1.4.2 Japan: Asia Pacific Pharmacovigilance and Drug Safety Software Market Breakdown, by Deployment
- 11.2.1.4.3 Japan: Asia Pacific Pharmacovigilance and Drug Safety Software Market Breakdown, by Enterprise Size
- 11.2.1.4.4 Japan: Asia Pacific Pharmacovigilance and Drug Safety Software Market Breakdown, by Form
- 11.2.1.5 South Korea: Asia Pacific Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031 (US$ Million)
- 11.2.1.5.1 South Korea: Asia Pacific Pharmacovigilance and Drug Safety Software Market Breakdown, by Offering
- 11.2.1.5.2 South Korea: Asia Pacific Pharmacovigilance and Drug Safety Software Market Breakdown, by Deployment
- 11.2.1.5.3 South Korea: Asia Pacific Pharmacovigilance and Drug Safety Software Market Breakdown, by Enterprise Size
- 11.2.1.5.4 South Korea: Asia Pacific Pharmacovigilance and Drug Safety Software Market Breakdown, by Form
- 11.2.1.6 Rest of Asia Pacific: Asia Pacific Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031 (US$ Million)
- 11.2.1.6.1 Rest of Asia Pacific: Asia Pacific Pharmacovigilance and Drug Safety Software Market Breakdown, by Offering
- 11.2.1.6.2 Rest of Asia Pacific: Asia Pacific Pharmacovigilance and Drug Safety Software Market Breakdown, by Deployment
- 11.2.1.6.3 Rest of Asia Pacific: Asia Pacific Pharmacovigilance and Drug Safety Software Market Breakdown, by Enterprise Size
- 11.2.1.6.4 Rest of Asia Pacific: Asia Pacific Pharmacovigilance and Drug Safety Software Market Breakdown, by Form
12. Competitive Landscape
12.1 Heat Map Analysis
12.2 Company Positioning and Concentration
13. Industry Landscape
13.1 Overview
13.2 Market Initiative
13.3 Partnerships and Collaborations
13.4 Other Developments
14. Company Profiles
14.1 Veeva Systems Inc
- 14.1.1 Key Facts
- 14.1.2 Business Description
- 14.1.3 Products and Services
- 14.1.4 Financial Overview
- 14.1.5 SWOT Analysis
- 14.1.6 Key Developments
14.2 IQVIA Holdings Inc
- 14.2.1 Key Facts
- 14.2.2 Business Description
- 14.2.3 Products and Services
- 14.2.4 Financial Overview
- 14.2.5 SWOT Analysis
- 14.2.6 Key Developments
14.3 AB Cube S.A.S.
- 14.3.1 Key Facts
- 14.3.2 Business Description
- 14.3.3 Products and Services
- 14.3.4 Financial Overview
- 14.3.5 SWOT Analysis
- 14.3.6 Key Developments
14.4 ArisGlobal LLC
- 14.4.1 Key Facts
- 14.4.2 Business Description
- 14.4.3 Products and Services
- 14.4.4 Financial Overview
- 14.4.5 SWOT Analysis
- 14.4.6 Key Developments
14.5 Oracle Corp
- 14.5.1 Key Facts
- 14.5.2 Business Description
- 14.5.3 Products and Services
- 14.5.4 Financial Overview
- 14.5.5 SWOT Analysis
- 14.5.6 Key Developments
14.6 Max Application
- 14.6.1 Key Facts
- 14.6.2 Business Description
- 14.6.3 Products and Services
- 14.6.4 Financial Overview
- 14.6.5 SWOT Analysis
- 14.6.6 Key Developments
14.7 ICON Plc
- 14.7.1 Key Facts
- 14.7.2 Business Description
- 14.7.3 Products and Services
- 14.7.4 Financial Overview
- 14.7.5 SWOT Analysis
- 14.7.6 Key Developments
14.8 Cognizant Technology Solutions Corp
- 14.8.1 Key Facts
- 14.8.2 Business Description
- 14.8.3 Products and Services
- 14.8.4 Financial Overview
- 14.8.5 SWOT Analysis
- 14.8.6 Key Developments
14.9 Accenture Plc
- 14.9.1 Key Facts
- 14.9.2 Business Description
- 14.9.3 Products and Services
- 14.9.4 Financial Overview
- 14.9.5 SWOT Analysis
- 14.9.6 Key Developments
14.10 Syneos Health Inc
- 14.10.1 Key Facts
- 14.10.2 Business Description
- 14.10.3 Products and Services
- 14.10.4 Financial Overview
- 14.10.5 SWOT Analysis
- 14.10.6 Key Developments
14.11 Genpact Ltd.
- 14.11.1 Key Facts
- 14.11.2 Business Description
- 14.11.3 Products and Services
- 14.11.4 Financial Overview
- 14.11.5 SWOT Analysis
- 14.11.6 Key Developments
14.12 Laboratory Corp of America Holdings
- 14.12.1 Key Facts
- 14.12.2 Business Description
- 14.12.3 Products and Services
- 14.12.4 Financial Overview
- 14.12.5 SWOT Analysis
- 14.12.6 Key Developments
14.13 Parexel International Corp
- 14.13.1 Key Facts
- 14.13.2 Business Description
- 14.13.3 Products and Services
- 14.13.4 Financial Overview
- 14.13.5 SWOT Analysis
- 14.13.6 Key Developments
14.14 Qinecsa Solutions
- 14.14.1 Key Facts
- 14.14.2 Business Description
- 14.14.3 Products and Services
- 14.14.4 Financial Overview
- 14.14.5 SWOT Analysis
- 14.14.6 Key Developments
14.15 Clinevo Technologies
- 14.15.1 Key Facts
- 14.15.2 Business Description
- 14.15.3 Products and Services
- 14.15.4 Financial Overview
- 14.15.5 SWOT Analysis
- 14.15.6 Key Developments
15. Appendix
15.1 About Business Market Insights
15.2 List of Abbreviations
Access the Full A Market Report
Get segment-level forecasts, regional estimates, competitive benchmarking, company profiles and downloadable Excel datasets.
